Ibogaine

N/A

Report date: 2025/05/06 16:57:08
NME

Base Information

Drug NameIbogaine
Drug Alias NameNIH-10567MSYNTH-001MC-106MC-808
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMu opioid receptor agonistsDopamine transporter agonistsSerotonin transporter agonists +[4] 
TargetsDopamine transporterMu opioid receptorKappa opioid receptor +[4] 
Therapy Area/IndicationsStress Disorders, Post-TraumaticCognitive DysfunctionAlcoholism +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesBrazil
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAjinomoto Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Sao Paulo
Inactive CompaniesJohns Hopkins University
Active IndicationsAlcoholism
Inactive IndicationsStress Disorders, Post-TraumaticCognitive DysfunctionBrain Injuries, Traumatic +[4] 

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG